|
Source |
Alliance of Genome Resources |



| Category | ID | Classification term | Gene | Evidence | Inferred from | Organism | Reference |
|---|---|---|---|---|---|---|---|
| Molecular Function | GO:0072570 | ADP-D-ribose binding | PARP9 | IMP | Human | PMID:26479788 | |
| Molecular Function | GO:0019899 | enzyme binding | PARP9 | IPI | UniProtKB:Q460N5 | Human | PMID:27796300 |
| Molecular Function | GO:0004857 | enzyme inhibitor activity | PARP9 | IDA | Human | PMID:27796300 | |
| Molecular Function | GO:0042393 | histone binding | PARP9 | IPI | UniProtKB:Q93079 | Human | PMID:26479788 |
| Molecular Function | GO:0003950 | NAD+ ADP-ribosyltransferase activity | PARP9 | IDA | Human | PMID:23230272 | |
| Molecular Function | GO:0140802 | NAD+-protein-C-terminal glycine ADP-ribosyltransferase activity | PARP9 | IDA | Human | PMID:28525742 | |
| Molecular Function | GO:0005515 | protein binding | PARP9 | IPI | UniProtKB:Q8TDB6 | Human | PMID:16809771 |
| Molecular Function | GO:0005515 | protein binding | PARP9 | IPI | UniProtKB:P09874 | Human | PMID:23230272 |
| Molecular Function | GO:0005515 | protein binding | PARP9 | IPI | UniProtKB:Q8TDB6 | Human | PMID:23230272 |
| Molecular Function | GO:0005515 | protein binding | PARP9 | IPI | UniProtKB:P42224,UniProtKB:Q8TDB6 | Human | PMID:26479788 |
| Molecular Function | GO:0005515 | protein binding | PARP9 | IPI | UniProtKB:P42224,UniProtKB:Q8TDB6,UniProtKB:Q93079 | Human | PMID:26479788 |
| Molecular Function | GO:0097677 | STAT family protein binding | PARP9 | IPI | UniProtKB:P42224 | Human | PMID:26479788 |
| Molecular Function | GO:0003714 | transcription corepressor activity | PARP9 | IMP | Human | PMID:16061477 | |
| Molecular Function | GO:0044389 | ubiquitin-like protein ligase binding | PARP9 | IPI | UniProtKB:Q8TDB6 | Human | PMID:28525742 |
| Cellular Component | GO:0005737 | cytoplasm | PARP9 | IDA | Human | PMID:16809771 | |
| Cellular Component | GO:0005737 | cytoplasm | PARP9 | IDA | Human | PMID:23230272 | |
| Cellular Component | GO:0005737 | cytoplasm | PARP9 | IDA | Human | PMID:26479788 | |
| Cellular Component | GO:0005737 | cytoplasm | PARP9 | IDA | Human | PMID:27796300 | |
| Cellular Component | GO:0005829 | cytosol | PARP9 | IDA | Human | GO_REF:0000052 | |
| Cellular Component | GO:0016020 | membrane | PARP9 | HDA | Human | PMID:19946888 | |
| Cellular Component | GO:0005739 | mitochondrion | PARP9 | IDA | Human | GO_REF:0000052 | |
| Cellular Component | GO:0005654 | nucleoplasm | PARP9 | IDA | Human | GO_REF:0000052 | |
| Cellular Component | GO:0005634 | nucleus | PARP9 | IDA | Human | PMID:26479788 | |
| Cellular Component | GO:0005634 | nucleus | PARP9 | IDA | Human | PMID:16809771 | |
| Cellular Component | GO:0005634 | nucleus | PARP9 | IDA | Human | PMID:23230272 | |
| Cellular Component | GO:0032991 | protein-containing complex | PARP9 | IDA | Human | PMID:26479788 | |
| Cellular Component | GO:0090734 | site of DNA damage | PARP9 | IDA | Human | PMID:28525742 | |
| Biological Process | GO:0000077 | DNA damage checkpoint signaling | PARP9 | IMP | Human | PMID:28525742 | |
| Biological Process | GO:0006302 | double-strand break repair | PARP9 | IMP | Human | PMID:23230272 | |
| Biological Process | GO:0043086 | negative regulation of catalytic activity | PARP9 | IDA | Human | PMID:27796300 | |
| Biological Process | GO:0010629 | negative regulation of gene expression | PARP9 | IMP | Human | PMID:27796300 | |
| Biological Process | GO:0000122 | negative regulation of transcription by RNA polymerase II | PARP9 | IMP | Human | PMID:16061477 | |
| Biological Process | GO:0035563 | positive regulation of chromatin binding | PARP9 | IGI | UniProtKB:Q8TDB6 | Human | PMID:26479788 |
| Biological Process | GO:0002230 | positive regulation of defense response to virus by host | PARP9 | IGI | UniProtKB:P42224,UniProtKB:Q8TDB6 | Human | PMID:26479788 |
| Biological Process | GO:0045893 | positive regulation of DNA-templated transcription | PARP9 | IGI | UniProtKB:P42224,UniProtKB:Q8TDB6 | Human | PMID:26479788 |
| Biological Process | GO:1900182 | positive regulation of protein localization to nucleus | PARP9 | IGI | UniProtKB:Q8TDB6 | Human | PMID:26479788 |
| Biological Process | GO:0060335 | positive regulation of type II interferon-mediated signaling pathway | PARP9 | IMP | Human | PMID:27796300 | |
| Biological Process | GO:0060335 | positive regulation of type II interferon-mediated signaling pathway | Parp9 | IMP | Mouse | MGI:MGI:5905929|PMID:27796300 | |
| Biological Process | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | PARP9 | IMP | Human | PMID:27796300 | |
| Biological Process | GO:0010608 | post-transcriptional regulation of gene expression | PARP9 | IMP | Human | PMID:26479788 | |
| Biological Process | GO:0060330 | regulation of response to type II interferon | PARP9 | IDA | Human | PMID:16809771 |
| EXP Inferred from experiment |
| IDA Inferred from direct assay |
| IEP Inferred from expression pattern |
| IGI Inferred from genetic interaction |
| IMP Inferred from mutant phenotype |
| IPI Inferred from physical interaction |
| HTP Inferred from High Throughput Experiment |
| HDA Inferred from High Throughput Direct Assay |
| HMP Inferred from High Throughput Mutant Phenotype |
| HGI Inferred from High Throughput Genetic Interaction |
| HEP Inferred from High Throughput Expression Pattern |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 01/06/2026 MGI 6.24 |
|
|
|
||